Samuel walking in parallel bars 19th of Mar 2015
Samuel is 7 years old and has an incomplete spinal cord injury after a bleeding at the C4-C6 level due to a cavernous angioma in late November 2014. He is from Sweden, but is undergoing rehabilitat.

By: Elin Salmiranta

Continue reading here:
Samuel walking in parallel bars 19th of Mar 2015 - Video

Recommendation and review posted by sam

Gluteal Neuromuscular Stimulation in Spinal Cord Injury
Liu LQ, Ferguson-pell M. Pressure Changes Under the Ischial Tuberosities During Gluteal Neuromuscular Stimulation in Spinal Cord Injury: A Comparison of Sacral Nerve Root Stimulation With Surface ...

By: Daryl Lawson

See the article here:
Gluteal Neuromuscular Stimulation in Spinal Cord Injury - Video

Recommendation and review posted by sam

WSCS 2014: DATA ANALYSIS NEEDS IN REGENERATIVE MEDICINE (SUPPORTED BY BIOSCIENCE TECHNOLOGY)
Moderator - Tim Studt, Advantage Media Speakers - Michele Reilly, Turing, Inc. Michael Vassar, MetaMed James M. Watt, PhD, Eagle Medical Services, LLC.

By: worldstemcell

Read the original post:
WSCS 2014: DATA ANALYSIS NEEDS IN REGENERATIVE MEDICINE (SUPPORTED BY BIOSCIENCE TECHNOLOGY) - Video

Recommendation and review posted by sam

Those hospitals and medical institutions advertising treatment of incurable diseases with stems cells are now under scanner of the Union Ministry of Health and Family Welfare.

The ministry has already processed complaints against at least 23 website advertisements.

The National Apex Committee for Stem Cell Research and Therapy (NACSCRT), under the Indian Council of Medical Research, has looped in Advertising Standards Council of India (ASCI) to monitor advertisements that claim to fully cure patients with stem cell based therapies.

Several clinics and organisations advertise stem cell therapies whose safety and efficacy are not proven, to attract vulnerable patients. As per the National Guidelines for Stem Cell Research 2013, stem cell therapy has not been proven effective other than in Hematopoietic Stem Cell Transplantation (HSCT) for haematological disorders (disorders which primarily affect the blood).

NAC-SCRT has observed that several clinicians, companies, hospitals advertise stem cell based therapies other than haematopoietic stem cell transplantation for haematological disorders on their websites. Officials clearly say that these therapies are currently investigational and must be conducted only within the scope of clinical trials.

Dr. Alok Srivastava, Chairman, NAC-SCRT said, "Advertisements claiming to offer stem cell-based therapies other than Haematopoietic Stem Cell Transplantations for blood diseases are in violation of the clause 10.3.1 of the National Guidelines for Stem Cell Research-2013."

"Use of stem cells for any other purpose outside the ambit of clinical trials will be against these guidelines and is hence not permissible. We have asked ASCI to review such advertisements and are happy that action has been initiated against 23 such websites. It is necessary that such misleading advertisements be removed and action be taken against the defaulters unless they are suitably modified to clarify the unproven nature of these therapies and are only offered within approved clinical trials. The NAC-SCRT will be reviewing the developments in the field and modifying its position with regard to proven therapies from time to time," he added.

As stem cell-based therapies are currently experimental, advertising these for results not approved by regulatory authorities is in violation of Chapter III of the ASCI code for Self-Regulation of Advertisements. "The code requires that advertisements should not propagate products or services, the use of which is banned under the law," said Narendra Ambwani, Chairman, ASCI.

Read this article:
Stem cell clinics under govt scanner

Recommendation and review posted by simmons

The pioneering treatment involves cells taken from a patients own body Theseare then reinjected into their heart to repair damaged muscle Could improve quality of life for patients suffering from heart failure This is caused by heart failing to pump enough blood around the body at the right pressure

By Roger Dobson and Katherine Keogh For The Mail On Sunday

Published: 17:16 EST, 21 March 2015 | Updated: 18:15 EST, 21 March 2015

144 shares

18

View comments

A pioneering treatment that uses stem cells to repair a broken heart could transform the lives of people with a potentially fatal cardiac condition.

The 15-minute procedure involves cells taken from a patients own body, which are then reinjected into their heart to repair damaged muscle.

It is hoped that the procedure could improve the quality of life for patients suffering from heart failure, which affects 900,000 people in the UK.

The condition is caused by the heart failing to pump enough blood around the body at the right pressure, because the muscle has become too weak or stiff to work properly. It causes breathlessness and extreme tiredness, and can even lead to sudden death.

Here is the original post:
How stem cells can fix a broken heart with just one jab

Recommendation and review posted by Bethany Smith

A student who gave the gift of life today urged more people to become bone marrow donors.

Matthew Bowker thought nothing about donating his bone marrow when it turned out he was a match to a patient desperately in need of help.

Matthew, a second year medical student at Newcastle University, agreed to undergo the donation procedure, and has never looked back since.

He said: It was all incredibly simple and I cant speak highly enough about the staff at Anthony Nolan who supported me throughout.

Anthony Nolan is the blood cancer charity behind the worlds first bone marrow donor register.

The organisation has now signed-up to support this summers British Transplant Games, which will take place at venues across the North East between July 30 and August 2.

Matthew, 23, said: For four days in a row, I had a nurse come round and give me a simple injection and then I went to London where I was attached to a machine which then took some stem cells. And that was it.

Matthew believes more people should sign the register in order to help.

Anthony Nolan has launched the Marrow year this academic year, announcing that one in five donors are recruited at universities.

This is because the students are perfect recruitment age and in general are young, fit, healthy people.

View original post here:
Newcastle student helps save a life through becoming a donor

Recommendation and review posted by Bethany Smith

The birth and engraftment of a blood stem cell | Boston Children's Hospital

When a patient receives a bone marrow transplant, the transplanted blood stem cells find their home, begin dividing and establish themselves in the body much like natural blood stem cells do. This zebrafish animation illustrates findings from the Stem Cell Research Program at Boston Children's Hospital that reveal this natural process for the first time, providing clues that will help scientists improve bone marrow transplants. Leonard Zon, MD, and colleagues published their full findings in the January 15, 2015 issue of Cell. Learn more: January 15, 2015 issue of Cell:

Happy Birthday Song Oh my genius brings u the most exciting and enjoyable birthday song for children.

Palmistry is also used to provide some important information about children. If you don't have your Janma Kundali, palmistry can help you to know whether you...

Subscribe to the KidsAnimations Youtube Channel - https://www.youtube.com/user/kidsanimations Click here to Watch our other God's & Goddess Of India Stories - https://www.youtube.com/watch?v=aXBZmFggZew&list=PLfv3tA5AoEjAWJlpkbjSfB2zt_nc9-1jn Become a KidsAnimations Fan on Facebook: https://www.facebook.com/superaudiomadras?ref=hl Playlists Hitopadesha Tales - https://www.youtube.com/watch?v=10dFGfFMXTg&list=PLfv3tA5AoEjBcrtyQ6iD3nSWPdUE1-UEz Prithviraj Chauhan Stories - https://www.youtube.com/watch?v=HgoFdV7l2mM&list=PLfv3tA5AoEjAjRUeOB_QH7Fq0-v56_MXm Akbar and Birbal Stories - https://www.youtube.com/watch?v=8RRgThKVvqY&list=PLfv3tA5AoEjDWDxKMXVCAdZY1P0irtNTf GIVE YOUR KIDS A BEST START IN LIFE.. THANKS FOR WATCHING FOR ONLINE PURCHASE VISIT US AT http://www.musicandchants.com/ Connect with us: google+: https://plus.google.com/111059833508006709219/posts facebook: https://www.facebook.com/superaudiomadras?ref=hl twitter: https://twitter.com/musicandchants Find us on http://www.pinterest.com/navindaswani5/ Hanuman (IPA: /hnmn/) is a Hindu god, who was an ardent devotee of Rama according to the Hindu legends. He is a central character in the Indian epic Ramayana and its various versions. He also finds mentions in several other texts, including Mahabharata, the various Puranas and some Jain texts. A vanara (monkey-like humanoid), Hanuman participated in Rama's war against the demon king Ravana. Several texts also present him as an incarnation of Lord Shiva. He is the son of Vayu, who according to several stories, played a role in his birth.

This is a reading and brief explanation of the poem by Anne Bradstreet and is intended for educational use only.

Old skool hip hop.

Share on Facebook - http://goo.gl/xvlMfo Tweet about this - http://goo.gl/VyFzby Share on g+ - http://goo.gl/BSCS5g The Bible is one continuous story made up of smaller, pivotal stories. Our collection of Bible stories highlight the simple yet intense truths found in the Bible. Each story is animated in a simple style to help the children understand the Bible better. These inspiring stories are narrated in a beautiful manner which will provide good moral values and lessons to children. Subscribe to this channel and stay tuned: http://www.youtube.com/subscription_center?add_user=rajshrikids Like our Facebook Page: http://www.facebook.com/rajshrikids Follow us on g+: https://plus.google.com/+rajshrikids

This talk was given at a local TEDx event, produced independently of the TED Conferences. Anita Collins shares how learning music influences our brain development, and what this means for musical education. Anita Collins was handed a clarinet at the age of 9, and it changed her life. This single event dictated her future career as a musician, music educator and academic. About TEDx, x = independently organized event In the spirit of ideas worth spreading, TEDx is a program of local, self-organized events that bring people together to share a TED-like experience. At a TEDx event, TEDTalks video and live speakers combine to spark deep discussion and connection in a small group. These local, self-organized events are branded TEDx, where x = independently organized TED event. The TED Conference provides general guidance for the TEDx program, but individual TEDx events are self-organized.* (*Subject to certain rules and regulations)

Join us as Grand Old Holy teaches lessons and stories from The Bible. Learn more about us at: http://fawesome.ifood.tv/. A carpenter named Joseph was soon to...

Continue reading here:
Watching over birth rates

Recommendation and review posted by Bethany Smith

Adoptive Cell Therapy, Patient Perspective - Melinda Bachini
From the Cholangiocarcinoma Foundation #39;s 2015 Annual Conference.

By: The Cholangiocarcinoma Foundation

Read more from the original source:
Adoptive Cell Therapy, Patient Perspective - Melinda Bachini - Video

Recommendation and review posted by Bethany Smith

Putting adoptive T cell therapy on the path to regulatory approval
Visit http://www.ecancer.org for more. Prof Ribas (UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA) talks to ecancertv at TAT 2015 about adoptive T-cell therapy approaches and their...

By: ecancer medicalscience

Original post:
Putting adoptive T cell therapy on the path to regulatory approval - Video

Recommendation and review posted by Bethany Smith

Designation supports the advancement of CTL019 to help address the unmet need of patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL) The filing was submitted by the University of Pennsylvania's Perelman School of Medicine which is conducting the CTL019 Phase I/II clinical trials Novartis and Penn have exclusive global collaboration to research, develop and commercialize CAR T cell therapies for the investigational treatment of cancers

Basel, July 7, 2014 - Novartis announced today that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL). The Breakthrough Therapy filing was submitted by the University of Pennsylvania's Perelman School of Medicine (Penn) which has an exclusive global agreement with Novartis to research, develop and commercialize personalized CAR T cell therapies for the treatment of cancers.

This is the fifth Breakthrough Therapy designation for Novartis, continuing the company's trajectory as a leader in developing innovative therapies to help treat diseases in which there remains significant unmet medical need[1],[2],[3],[4]. Novartis' Zykadia(TM) (ceritinib, previously known as LDK378), for the treatment of anaplastic lymphoma kinase positive (ALK+) metastatic non-small cell lung cancer (NSCLC), is one of the first medicines to receive an FDA approval following earlier receipt of Breakthrough Therapy designation by the FDA[5].

"This Breakthrough Therapy designation underscores the potential of CTL019 as a life-saving therapy for patients with relapsed/refractory ALL, who are in desperate need of new treatment options," said David Epstein, Division Head, Novartis Pharmaceuticals. "Novartis welcomes increased dialogue with the FDA and a potentially expedited review to streamline the development of CTL019 and hopefully bring this promising therapy to patients as quickly as possible."

According to the FDA, Breakthrough Therapy designation is intended to expedite the development and review of new medicines that treat serious or life-threatening conditions if the therapy has demonstrated substantial improvement over an available therapy on at least one clinically significant endpoint. The designation includes all of the fast track program features, as well as more intensive FDA guidance. It is a distinct status from both accelerated approval and priority review, which can also be granted to the same drug if relevant criteria are met[6].

"This is a major milestone as we are now one step closer in helping address the high unmet needs of this patient population," said Carl H. June, M.D., Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine in the Perelman School of Medicine and director of Translational Research in the Abramson Cancer Center of the University of Pennsylvania. "We are excited about the strength of the positive early data seen in pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia and look forward to building upon these findings as we continue advancing the CTL019 clinical program in Phase II trials."

Novartis recently established the Cell and Gene Therapies Unit under the leadership of Usman Azam, Global Head, to bring an intense focus on advancing innovative cell-based therapies, including the development of CARs. Novartis holds the worldwide rights to CARs developed through the collaboration with Penn for all cancer indications, including the lead program, CTL019.

About CTL019 CTL019 uses CAR technology to reprogram a patient's own T cells to "hunt" cancer cells that express specific proteins, called CD19. After they have been reprogrammed, the T cells (now called CTL019) are re-introduced into the patient's blood; they proliferate and bind to the targeted CD19+ cancer cells and destroy them.

Because CTL019 is an investigational therapy, the safety and efficacy profile has not yet been established. Access to investigational therapies is available only through carefully controlled and monitored clinical trials. These trials are designed to better understand the potential benefits and risks of the therapy. Because of uncertainty of clinical trials, there is no guarantee that CTL019 will ever be commercially available anywhere in the world.

About Acute Lymphoblastic Leukemia Acute lymphoblastic leukemia (ALL) is the most common cancer diagnosed in children, representing approximately 25% of cancer diagnoses among children younger than 15 years[7]. It can also occur in adults. ALL is a type of cancer in which the bone marrow makes too many abnormal white blood cells (lymphocytes). ALL usually gets worse quickly if it is not treated and can be fatal within a few months; therefore it is critical for patients to start treatment soon after diagnosis. Patients with relapsed ALL experience ALL cells returning in the marrow and a decrease in normal blood cells following their remission. Patients with refractory ALL still have leukemia cells in their bone marrow following treatment[8].

Original post:
Novartis personalized cell therapy CTL019 receives FDA ...

Recommendation and review posted by Bethany Smith

The Sims 3 | Perfect Genetics Challenge #1 - Azkadellia Settles In
I take on the Perfect Genetics Challenge for The Sims 3! Azkadellia Ideal settles in to her new home and a new job! Challenge Rules: --------- Perfect Genetics Challenge - http://modthesims.info/t...

By: Stacy Place

View post:
The Sims 3 | Perfect Genetics Challenge #1 - Azkadellia Settles In - Video

Recommendation and review posted by Bethany Smith

Quick Medical Genetics - Aicardi syndrome
This is a lecture about the genetic disease Aicardi syndrome for trainees and medical professionals. Lecture by Philip M. Boone, MD, PhD. References: http://www.omim.org/entry/304050 http://www.nc...

By: Quick Medical Genetics

Read more here:
Quick Medical Genetics - Aicardi syndrome - Video

Recommendation and review posted by Bethany Smith

Ponderlust | Ep. 5: Genetics

By: Endeavorist

See the rest here:
Ponderlust | Ep. 5: Genetics - Video

Recommendation and review posted by Bethany Smith

Gene therapy for CCALD
Description.

By: bluebird bio

See the rest here:
Gene therapy for CCALD - Video

Recommendation and review posted by Bethany Smith

stem cell medicine Jakarta tangerang serpong bsd bintaro
http://youtu.be/e8ihj9O6b-4 http://youtu.be/kbpkTtpqBBw.

By: Layar Baru DKI

Read the rest here:
stem cell medicine Jakarta tangerang serpong bsd bintaro - Video

Recommendation and review posted by simmons

SuperCells at Centre for Life
Exhibition at Centre for Life, Newcastle. Exhibition presented by the Stem Cell Network and produced by the Sherbrooke Museum of Nature and Science (Quebec, Canada); in partnership with the...

By: Cell Therapy Catapult

Read the rest here:
SuperCells at Centre for Life - Video

Recommendation and review posted by simmons

Stem Cell Injection Treatment Stem Cell Therapy
Salah satu kaedah perawatan menggunakan Sel Induk dari Tulan Belakang.. Untuk maklumat lanjut boleh call/WA/Telegram/SMS ke 013-3530172 atau layarai web http://www.cellmaxx4all.com.

By: KAMARUZAMAN DERAMAN

More:
Stem Cell Injection Treatment Stem Cell Therapy - Video

Recommendation and review posted by simmons

Knee arthritis 3 years after stem cell therapy by Harry Adelson, N.D.
Donna from Colorado describes her outcome three years after stem cell therapy for her arthritic knee by Harry Adelson, N.D. http://www.docereclinics.com.

By: Harry Adelson, N.D.

Here is the original post:
Knee arthritis 3 years after stem cell therapy by Harry Adelson, N.D. - Video

Recommendation and review posted by simmons

stem cell therapy di indonesia Jakarta tangerang serpong bsd bintaro
http://youtu.be/3c259RtpzpE.

By: Layar Baru DKI

More here:
stem cell therapy di indonesia Jakarta tangerang serpong bsd bintaro - Video

Recommendation and review posted by simmons

My Conversation with Ralph Snyderman, Father of Personalized Medicine (Pt 2)
In Part 2 of this video series, Ralph Snyderman MD and Pat Salber MD (@docweighsin) discuss the challenge of engaging the unengaged patient. Just telling folks what they need to do to stay...

By: The Doctor Weighs In

Read the original:
My Conversation with Ralph Snyderman, Father of Personalized Medicine (Pt 2) - Video

Recommendation and review posted by sam

My Conversation with Ralph Snyderman, Father of Personalized Medicine (Pt 1)
Ralph Snyderman MD, Chancellor Emeritus of Duke University has been called the Father of Personalized Medicine. Who better to help us understand what #39;s going on in this exciting field. In this...

By: The Doctor Weighs In

Original post:
My Conversation with Ralph Snyderman, Father of Personalized Medicine (Pt 1) - Video

Recommendation and review posted by sam

Brandon spinal cord injury leg extensions

By: pressingontx

Visit link:
Brandon spinal cord injury leg extensions - Video

Recommendation and review posted by sam

Teaching Independent Transfers for Spinal Cord Injury Video: Jennifer Hastings | MedBridge
Watch the first chapter FREE: https://www.medbridgeeducation.com/courses/details/teaching-independent-transfers-for-spinal-cord-injury Instructor: Jennifer Hastings, PT, PhD, NCS In this...

By: MedBridge

See the article here:
Teaching Independent Transfers for Spinal Cord Injury Video: Jennifer Hastings | MedBridge - Video

Recommendation and review posted by sam

The Prolotherapist: Fox Morning Blend, March 10, 2015
Ross Hauser, MD discusses hip arthritis on Fox 4 Morning Blend in southwest Florida. If you have hip arthritis, or other hip pain, we would love to help you. We treat much more than hips too!...

By: Caring Medical Regenerative Medicine Clinics

Read more:
The Prolotherapist: Fox Morning Blend, March 10, 2015 - Video

Recommendation and review posted by sam

David Kekich - Regenerative Medicine (Part 3/6)
Visit Dr mercola #39;s Amazon product page: http://www.amazon.com/s/?

By: MercolaHealthVideos

See the article here:
David Kekich - Regenerative Medicine (Part 3/6) - Video

Recommendation and review posted by sam